Misplaced Pages

Estradiol benzoate/progesterone/methandriol dipropionate (EB/P4/MADP), sold under the brand name Progestandron (Organon), is an injectable combination medication of estradiol benzoate (EB), an estrogen, progesterone (P4), a progestogen, and methandriol dipropionate (MADP), an androgen/anabolic steroid. It contained 3 mg EB, 20 mg P4, and 50 mg MADP, was provided in the form of ampoules, and was administered by intramuscular injection. The medication was marketed by 1957. It is no longer available.

See also

• List of combined sex-hormonal preparations § Estrogens, progestogens, and androgens

References

1. ^ Silló G (1958). "Komplexhormon bei Menopause und Hypertonie". Hormone und Psyche die Endokrinologie des Alternden Menschen: Fünftes Symposion der Deutschen Gesellschaft für Endokrinologie Freiburg (Breisgau), den 7. bis 9. März 1957. Springer. pp. 53–57. doi:10.1007/978-3-642-87014-9_9. ISBN 978-3-642-87014-9.
2. ^ Ufer J (1960). Hormontherapie in der Frauenheilkunde: Grundlagen und Praxis. Gruyter. p. 155. ISBN 9783111138770.
3. "Progestandron". drugs.com.

This drug article relating to the genito-urinary system is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Abandoned drugs
• Combined estrogen–progestogen–androgen formulations
• Genito-urinary system drug stubs